CRIS Current Research Information System

BORIANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.609
EU - Europa 16.049
AS - Asia 5.333
AF - Africa 808
SA - Sud America 30
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 10
Totale 39.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.574
GB - Regno Unito 5.239
IT - Italia 2.478
DE - Germania 2.319
CN - Cina 2.210
VN - Vietnam 1.971
UA - Ucraina 1.925
SE - Svezia 1.188
IN - India 934
FR - Francia 765
RU - Federazione Russa 679
IE - Irlanda 574
EE - Estonia 445
ZA - Sudafrica 330
SC - Seychelles 161
CI - Costa d'Avorio 147
TG - Togo 118
FI - Finlandia 75
CH - Svizzera 73
BG - Bulgaria 67
JO - Giordania 50
BE - Belgio 46
NG - Nigeria 45
GR - Grecia 44
IR - Iran 38
NL - Olanda 38
CA - Canada 32
JP - Giappone 32
LB - Libano 26
PL - Polonia 16
UZ - Uzbekistan 15
AU - Australia 14
RO - Romania 14
CL - Cile 13
CZ - Repubblica Ceca 13
HR - Croazia 13
BR - Brasile 12
KR - Corea 12
AT - Austria 10
TR - Turchia 10
ES - Italia 8
EU - Europa 7
NZ - Nuova Zelanda 7
SG - Singapore 7
HK - Hong Kong 5
BD - Bangladesh 4
HU - Ungheria 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
NO - Norvegia 3
PT - Portogallo 3
TH - Thailandia 3
AR - Argentina 2
DK - Danimarca 2
MD - Moldavia 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
HT - Haiti 1
ID - Indonesia 1
IQ - Iraq 1
KW - Kuwait 1
LU - Lussemburgo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
Totale 39.860
Salva come PNG Salva come JPEG
Città #
Southend 4.731
Fairfield 2.538
Ashburn 1.537
Jacksonville 1.378
Wilmington 1.281
Woodbridge 1.166
Seattle 1.133
Princeton 1.112
Chandler 1.098
Houston 1.067
Cambridge 869
Dong Ket 788
Ann Arbor 659
Dublin 573
Westminster 506
Padova 503
Nanjing 472
Berlin 308
Medford 255
Saint Petersburg 254
Jinan 227
Shenyang 223
Mülheim 215
San Diego 188
Milan 175
Mahé 160
Changsha 157
Hebei 157
Bologna 152
Abidjan 147
Nanchang 147
Bremen 122
Lomé 118
Beijing 106
Jiaxing 99
Turin 97
New York 91
Olalla 88
Boardman 85
Des Moines 85
Tianjin 85
Verona 82
Rome 78
Helsinki 74
Norwalk 73
Dearborn 66
Sofia 62
Ningbo 59
Falls Church 58
Haikou 58
Zhengzhou 57
Hangzhou 55
Amman 50
Mountain View 48
Brussels 44
San Venanzo 44
Abeokuta 42
Lanzhou 42
Bern 40
Bühl 38
Kunming 36
Taizhou 36
Florence 33
London 30
Guangzhou 29
Taiyuan 28
Tokyo 27
Bari 26
Redmond 26
Redwood City 25
Los Angeles 24
Fuzhou 20
Frankfurt Am Main 19
Ardabil 18
Monmouth Junction 18
Toronto 18
Leawood 17
Paris 17
Genzano Di Roma 16
Pune 16
Chicago 14
Hefei 14
Monterotondo 14
Plauen 14
Lausanne 13
Phoenix 12
Andover 11
Costa Mesa 11
Groningen 11
Den Haag 10
Frankfurt am Main 10
Washington 10
Catania 9
Kiev 9
Kuban 9
Messina 9
Muizenberg 9
Napoli 9
Augusta 8
Grafing 8
Totale 26.915
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 641
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 274
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 209
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 176
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 175
Aritimie cardiache, morte cardiaca improvvisa, sincope 169
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 166
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 157
La tachicardiomiopatia: una revisione della letteratura 156
AF burden is important - Fact or fiction? 149
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 148
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 147
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 144
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 144
Incidenza e fattori predittivi di fibrillazione atriale post operatoria nei riceventi di trapianto renale 143
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 142
Atrial fibrillation ablation: beyond electro-mechanical matters 139
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 138
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 136
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 134
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 132
Automatic verification of ventricular stimulation: fusion management algorithm 131
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 131
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 130
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 129
Electrocardiographic remodeling during cardiac resynchronization therapy 127
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 127
Rate control in AFFIRM: considerations about the clinical implications. 126
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 126
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 124
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 124
Atrial fibrillation and heart failure: does one epidemic feed he other? 122
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 122
Automatic management of left ventricular stimulation: hints for technologic improvement. 121
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. 121
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 121
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 120
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 120
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 119
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 119
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 119
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 118
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 117
Solution to a crushing dosage problem? 116
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 116
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 115
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 115
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 115
Heart failure after myocardial revascularization: Risk markers. 114
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 114
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 114
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 112
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 112
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 111
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter 111
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 111
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 110
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients. 110
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 109
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 109
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 108
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 108
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 107
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 107
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 107
A plateau waveform shape allows a much higher patient shock energy tolerance 107
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 107
Cardiac resynchronization by pacing: an electrical treatment of heart failure 107
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 106
Comparison of two strategies to reduce ventricular pacing in pacemaker patients 106
Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. 105
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 105
Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment? 104
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 104
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. 104
Cardiac resynchronization therapy: a cost or an investment? 104
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. 104
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 104
Automatic verification of ventricular stimulation: fusion management algorithm 104
Far-field R wave oversensing in dual-chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance 103
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 103
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 103
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 103
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 102
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 101
A randomised comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from bradycardia and atrial fibrillation and implanted with a DDDRP device 101
Duration of P-wave is associated with atrial fibrillation hospitalizations in patients with atrial fibrillation and paced for bradycardia. 101
The QRS interval in patients treated with resynchronization therapy: which value 101
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 101
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 101
Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias. 100
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 100
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 100
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 100
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 99
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 99
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 99
Implantation of cardioverter-defibrillator: Effects on shoulder function. 99
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 99
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 99
Totale 12.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.496 0 0 0 0 0 0 0 0 0 703 174 619
2019/202012.369 2.157 346 287 823 1.031 1.169 1.362 1.538 1.414 789 367 1.086
2020/20216.935 1.552 485 174 397 97 325 62 402 394 392 335 2.320
2021/20227.490 672 377 511 628 774 554 146 603 236 254 1.164 1.571
2022/20236.922 851 887 354 956 380 378 212 349 1.139 335 655 426
2023/20241.506 136 286 114 122 176 276 120 88 82 106 0 0
Totale 40.545